
Join to View Full Profile
1 Medical Plaza DriveSuite 430Irvine, CA 92697
Phone+1 949-824-8600
Fax+1 914-366-5301
Dr. Swope is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- David Swope, MD, is a neurologist located in Irvine, CA, with a subspecialty in movement disorders. He is Chief of the Movement Disorders division at University of California, Irvine. He obtained his medical degree from Loma Linda University School of Medicine, completed his residency in neurology and internal medicine at Loma Linda University Health Education Consortium, and a fellowship in neuromuscular medicine at the Icahn School of Medicine at Mount Sinai. Dr. Swope currently serves as a Professor at UC Irvine Health Gottschalk Medical Plaza and as a Clinical Associate Professor at NYU Langone Health. He has clinical expertise in movement disorders, and dystonia treatment with botulinum toxin injections. His research work has been published in several reputable journals, covering topics such as cervical dystonia and Parkinson's disease. He has also been involved in clinical trials, including studying zonisamide for essential tremor and sildenafil for dyskinesias in Parkinson's disease.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Neuromuscular Medicine (Neurology), 1995 - 1997
Loma Linda University Health Education ConsortiumResidency, Neurology, 1991 - 1994
Loma Linda University Health Education ConsortiumResidency, Internal Medicine, 1989 - 1991
Loma Linda University School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1990 - 2028
NY State Medical License 1995 - 2020
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Zonisamide in the Treatment of Essential Tremor Start of enrollment: 2003 Jun 01
- Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease Start of enrollment: 2002 Feb 01
Publications & Presentations
PubMed
- Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure.Richard L Barbano, Bahman Jabbari, Marjan Sadeghi, Ahunna Ukah, Emma Yue
Toxins. 2025-03-19 - 1 citationsCase report: Approaches to treatment-refractory and super-refractory glutamic acid decarboxylase antibody-spectrum disorders.Ravi Rajmohan, Shivali Baveja, Dai Nguyen, Eshita Shah, Michael Sy
Frontiers in Immunology. 2023-01-01 - 6 citationsAceruloplasminemia and putaminal cavitation.Giulietta Riboldi, Kara Anstett, Rajan Jain, Heather Lau, David M. Swope
Parkinsonism & Related Disorders. 2018-03-07
Professional Memberships
- American Neurologic AssociationFellow
- Movement Disorders SocietyMember
- American Academy of NeurologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









